ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1337

Pulmonary Computed Tomography Changes in Patients with Rheumatoid Arthritis

Alexandra Balbir-Gurman1, Ludmila Guralnik2, Mordehai Yigla3, Yolanda Braun-Moscovici4, Anna Astrahan5 and Emilia Hardak6, 1B. Shine Rheumatology Unit, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion - Institute of Technology, Haifa, Israel, 2Department of Diagnostic Imaging, Rambam Health Care Campus, The Bruce Rappaport Faculty of Medicine, Technion-Institute of Technology, Haifa, Israel, 3Division of Pulmonary Medicine, Rambam Health Care Campus, The Bruce Rappaport Faculty of Medicine, Technion-Institute of Technology, Haifa, Israel, 4B Shine Department of Rheumatology, Rambam Health Care Campus,. Rappaport Faculty of Medicine, Technion, Haifa, Israel, 5Rappaport Faculty of Medicine-Technion, Israeli Institute of Technology, Haifa, Israel, 6Pulmonary Institute, Rambam Health Care Campus; Rappaport Faculty of Medicine-Technion, Israeli Institute of Technology, Haifa, Israel

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Computed tomography (CT), interstitial lung disease and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Imaging of Rheumatic Diseases Poster II: X-ray, MRI, PET and CT

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Lung involvement in RA it is often diagnosed in advanced stage. Chest CT is the main modality for assessment of ILD. To analyze chest CT changes in a cohort of RA patients followed at our center and their correlation with RA features and prognosis.

Methods: Chest CT scans performed by RA patients were retrospectively analyzed. CT findings were classified as RA-lung and non-RA-lung and correlated to patients data (age, sex, RA duration, smoking, death, DAS28, joint erosions, extra-articular features, CRP, RF, ACPA, FVC, DLCO), and treatment. The search of the MEDLINE was performed using keyword combinations: RA and chest CT; rheumatoid lung and chest CT; RA and ILD  for the period from 1991 until 2015. Statistical analysis included logistic regression. P-value <0.05 was defined as significant.

Results: 48 out of 84 patients (57.2%) had RA-lung. Positive RF (p=0.018), joint erosions (p=0.003) and reduced DLCO (p=0.005) correlated with RA-lung. Treatment with DMARDs had protective effect against RA-lung (p=0.028). Analyzed published literature (100 original articles, reviews and case reports) on chest CT in RA reported on changes in the lung parenchyma, pleura, bronchial system, and the vasculature. CT changes were attributed to RA-lung (mainly ILD) or non-related to RA (new or existing lung pathology, drug induced pneumonitis, and conventional and opportunistic infections, especially in patients treated with synthetic and/or biological DMARDs).

Conclusion: Findings on chest CT attributed to ILD-RA in the literature are variable and difficult for interpretation and classification. Correlation of CT findings with clinical data according to analyzed literature is not fully estimated. There is an unmet need to design an algorithm for prediction of CT changes compatible with ILD-RA with a high probability. Our data indicates that in RA patients with high RF, erosive disease and reduced DLCO there is a high probability for abnormal chest CT study, especially for ILD-RA. Diagnosing of ILD-RA early could allow comprehensive approach to treatment with possible control of both, RA and RA-lung disease; early intervention may change the course of RA and ILD-RA with possible slowing and prevention the progression of ILD-RA toward pulmonary fibrosis.


Disclosure: A. Balbir-Gurman, None; L. Guralnik, None; M. Yigla, None; Y. Braun-Moscovici, None; A. Astrahan, None; E. Hardak, None.

To cite this abstract in AMA style:

Balbir-Gurman A, Guralnik L, Yigla M, Braun-Moscovici Y, Astrahan A, Hardak E. Pulmonary Computed Tomography Changes in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/pulmonary-computed-tomography-changes-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pulmonary-computed-tomography-changes-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology